{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:35Z","timestamp":1787022095028,"version":"build-2736575974"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In resource-limited settings, the mortality rate among tuberculosis and human Immunodeficiency virus co-infected children is higher. However, there is no adequate evidence in Ethiopia in general and in the study area in particular. Hence, this study aims to estimate lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest Ethiopia Hospitals, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Institution-based historical follow-up study was conducted in Northwest Ethiopia Hospitals among 227 Tuberculosis and Human Immunodeficiency Virus co-infected children from March 1, 2014, to January 12, 2021. The data were entered into Epi info-7 and then exported to STATA version 14 for analysis. The log-rank test was used to estimate the curve difference of the predictor variables. Bivariable cox-proportional hazard models were employed for each predictor variable. Additionally, those variables having a p-value &lt; 0.25 in bivariate analysis were fitted into a multivariable cox-proportional hazards model. P-value &lt; 0.05 was used to declare significance associated with the dependent variable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From a total of 227 TB and HIV co-infected children, 39 died during the follow-up period. The overall mortality rate was 3.7 (95% CI (confidence interval): 2.9\u20134.7) per 100 person-years with a total of 1063.2-year observations. Cotrimoxazole preventive therapy (CPT) non-users [Adjusted Hazarded Ratio (AHR) = 3.8 (95% CI: 1.64\u20138.86)], presence of treatment failure [AHR = 3.0 (95% CI: 1.14\u201378.17)], and Cluster of differentiation 4(CD4) count below threshold [AHR = 2.7 (95% CI: 1.21\u20136.45)] were significant predictors of mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, the mortality rate among TB and HIV co-infected children was found to be very high. The risk of mortality among TB and HIV co-infected children was associated with treatment failure, CD4 count below the threshold, and cotrimoxazole preventive therapy non-users. Further research should conduct to assess and improve the quality of ART service in Northwest Ethiopia Hospitals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0258964","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:33:55Z","timestamp":1640093635000},"page":"e0258964","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-5380","authenticated-orcid":true,"given":"Ermias Sisay","family":"Chanie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet Asmare","family":"Gelaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye Yimer","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejen Getaneh","family":"feleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubet Taklual","family":"Admas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetie","family":"Molla Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-8903","authenticated-orcid":true,"given":"Melkalem Mamoye","family":"Azanaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofonyas Abebaw","family":"Tiruneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu Digssie","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyam Minuye","family":"Birhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-4402","authenticated-orcid":true,"given":"Wubet Alebachew","family":"Bayih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Aragie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"pone.0258964.ref001","article-title":"Tuberculosis and HIV\u2014An Update on the \u201cCursed Duet\u201d in Children","volume":"7","author":"S. H.-L. Fry","year":"2019","journal-title":"Front. Pediatr."},{"key":"pone.0258964.ref002","unstructured":"\u2018About HIV\/AIDS | HIV Basics | HIV\/AIDS | CDC\u2019, Dec. 02, 2019. https:\/\/www.cdc.gov\/hiv\/basics\/whatishiv.html (accessed Jun. 08, 2020)."},{"issue":"2","key":"pone.0258964.ref003","first-page":"2013","article-title":"Survival of HIV-TB co-infected adult patients under ART in Ambo Referral Hospital, Ethiopia","volume":"27","author":"H. Refera","journal-title":"Ethiop. J. Health Dev."},{"key":"pone.0258964.ref004","volume-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"pone.0258964.ref005","unstructured":"\u2018HIV and Tuberculosis (TB) Understanding HIV\/AIDS\u2019, AIDSinfo. https:\/\/aidsinfo.nih.gov\/understanding-hiv-aids\/fact-sheets\/26\/90\/hiv-and-tuberculosis\u2014tb- (accessed Jun. 15, 2020)."},{"key":"pone.0258964.ref006","unstructured":"\u2018Global Tuberculosis Report 2020\u2019. https:\/\/repository.gheli.harvard.edu\/repository\/10993\/ (accessed Jul. 24, 2021)."},{"issue":"2","key":"pone.0258964.ref007","first-page":"2011","article-title":"\u2018Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria\u2019","volume":"14","author":"A. A. Okechukwu","journal-title":"Niger. J. Clin. Pract"},{"issue":"10","key":"pone.0258964.ref008","doi-asserted-by":"crossref","first-page":"e0203986","DOI":"10.1371\/journal.pone.0203986","article-title":"The twin epidemics: Prevalence of TB\/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis","volume":"13","author":"B. Tesfaye","year":"2018","journal-title":"PLOS ONE"},{"key":"pone.0258964.ref009","unstructured":"\u2018TB and HIV\u2019, TB Alert. https:\/\/www.tbalert.org\/about-tb\/global-tb-challenges\/tb-hiv\/ (accessed Jun. 08, 2020)."},{"key":"pone.0258964.ref010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/157016207781662434","article-title":"Clinical Presentation, Treatment Outcome and Survival Among the HIV Infected Children with Culture Confirmed Tuberculosis","volume":"5","author":"A. Kumar","year":"2007","journal-title":"Curr. HIV Res."},{"key":"pone.0258964.ref011","unstructured":"\u2018Tuberculosis in Children\u2019, UNICEF DATA. https:\/\/data.unicef.org\/topic\/child-health\/tuberculosis\/ (accessed Jun. 25, 2020)."},{"key":"pone.0258964.ref012","unstructured":"\u2018TB and HIV\u2014Co-infection, diagnosis & treatment\u2019, TBFacts, Jun. 08, 2020. https:\/\/tbfacts.org\/tb-hiv\/ (accessed Jun. 08, 2020)."},{"key":"pone.0258964.ref013","first-page":"21","article-title":"Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment","volume":"3","author":"C. Au-Yeung","year":"2011","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"pone.0258964.ref014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5588\/pha.15.0027","article-title":"HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria","volume":"5","author":"O. J. Daniel","year":"2015","journal-title":"Public Health Action"},{"issue":"12","key":"pone.0258964.ref015","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"S. D. Lawn","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"pone.0258964.ref016","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2334-14-S1-S5","article-title":"Tuberculosis and HIV co-infection in children","volume":"14","author":"E. Venturini","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"15","key":"pone.0258964.ref017","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis\u2019","volume":"29","author":"R. K. Gupta","year":"2015","journal-title":"AIDS Lond. Engl.,"},{"key":"pone.0258964.ref018","unstructured":"\u2018WHO | TB causes 1 in 3 HIV deaths\u2019, WHO. http:\/\/www.who.int\/hiv\/mediacentre\/news\/hiv-tb-patient-centred-care\/en\/ (accessed Jun. 15, 2020)."},{"issue":"Suppl 1","key":"pone.0258964.ref019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4314\/ejhs.v27i1.4S","article-title":"Factors Associated with Mortality of TB\/HIV Co-infected Patients in Ethiopia","volume":"27","author":"A. M. Teklu","year":"2017","journal-title":"Ethiop. J. Health Sci."},{"issue":"55","key":"pone.0258964.ref020","article-title":"Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study\u2019","volume":"13","author":"K. A. Atalell","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"pone.0258964.ref021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1471-2458-9-409","article-title":"Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis","volume":"9","author":"F. M. Mugusi","year":"2009","journal-title":"BMC Public Health"},{"key":"pone.0258964.ref022","unstructured":"\u2018Causes of Death in HIV-infected Persons Who Have Tuberculosis, Thailand\u2019. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2657626\/ (accessed Jun. 03, 2020)."},{"issue":"4","key":"pone.0258964.ref023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.11599\/germs.2016.1099","article-title":"Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study","volume":"6","author":"A. O. Ebonyi","year":"2016","journal-title":"Germs"},{"issue":"4","key":"pone.0258964.ref024","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4314\/ahs.v14i4.12","article-title":"Mortality associated with tuberculosis\/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa","volume":"14","author":"T. Mabunda","year":"2015","journal-title":"Afr. Health Sci.,"},{"issue":"1","key":"pone.0258964.ref025","doi-asserted-by":"crossref","DOI":"10.4102\/phcfm.v10i1.1765","article-title":"A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and\/or antiretroviral therapy protect against death?","volume":"10","author":"S. Tshitenge","year":"2018","journal-title":"Afr. J. Prim. Health Care Fam. Med"},{"issue":"01","key":"pone.0258964.ref026","doi-asserted-by":"crossref","DOI":"10.26502\/aimr.006","article-title":"Risk Factors for Mortality in Patients with TB\/HIV Co-Infection at the General Provincial Reference Hospital of Kinshasa, Democratic Republic of the Congo","volume":"02","author":"P. Ansot Anzats Ruphine","year":"2019","journal-title":"Arch. Intern. Med. Res"},{"issue":"1","key":"pone.0258964.ref027","first-page":"7","article-title":"Predictors of Time to Death among TB\/HIV Co-Infected Adults on ART at Two Governmental Hospitals in Mekelle, Ethiopia, 2009\u20132016: A Retrospective Cohort Study","volume":"5","author":"K. E. Gezae","year":"2020"},{"key":"pone.0258964.ref028","unstructured":"Amanda Butler, \u2018Underdeveloped: Healthcare in Developing Nations\u2019, Orbis Biosciences. https:\/\/orbisbio.com\/underdeveloped-healthcare-in-developing-nations\/ (accessed Feb. 09, 2021)."},{"key":"pone.0258964.ref029","volume-title":"Disease Control Priorities in Developing Countries","author":"J. W. Peabody","year":"2006","edition":"2"},{"key":"pone.0258964.ref030","first-page":"10","article-title":"Survival rate and mortality risk factors among TB\u2013HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study","volume":"80","author":"Int","year":"2019","journal-title":"J. Infect. Dis."},{"key":"pone.0258964.ref031","unstructured":"\u2018Children With HIV and AIDS: An Overview\u2019, WebMD. https:\/\/www.webmd.com\/hiv-aids\/guide\/hiv-in-children (accessed Feb. 09, 2021)."},{"issue":"4","key":"pone.0258964.ref032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","article-title":"Idiopathic CD4 lymphocytopenia","volume":"18","author":"U. A. Walker","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"pone.0258964.ref033","unstructured":"\u2018When to start HIV treatment | Terrence Higgins Trust\u2019. https:\/\/www.tht.org.uk\/hiv-and-sexual-health\/living-well-hiv\/hiv-treatment\/when-start-hiv-treatment (accessed Feb. 09, 2021)."},{"key":"pone.0258964.ref034","unstructured":"\u2018Treatment | Living with HIV | HIV Basics | HIV\/AIDS | CDC\u2019, Oct. 21, 2020. https:\/\/www.cdc.gov\/hiv\/basics\/livingwithhiv\/treatment.html (accessed Feb. 09, 2021)."},{"key":"pone.0258964.ref035","unstructured":"J. Myhre, D. Sifris, and MD, \u2018What To Do If An HIV Treatment Fails\u2019, Verywell Health. https:\/\/www.verywellhealth.com\/what-to-do-if-an-hiv-treatment-fails-49163 (accessed Jul. 24, 2021)."},{"issue":"1","key":"pone.0258964.ref036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12981-020-00294-z","article-title":"Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia","volume":"17","author":"J. Nega","year":"2020","journal-title":"AIDS Res. Ther."},{"issue":"12","key":"pone.0258964.ref037","doi-asserted-by":"crossref","first-page":"e1717","DOI":"10.1016\/S2214-109X(19)30422-X","article-title":"Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial","volume":"7","author":"B. Daniels","year":"2019","journal-title":"Lancet Glob. Health"},{"issue":"7","key":"pone.0258964.ref038","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2214-109X(16)30096-1","article-title":"Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial","volume":"4","author":"J. A. Berkley","year":"2016","journal-title":"Lancet Glob. Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:34:35Z","timestamp":1640093675000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258964"}},"subtitle":[],"editor":[{"given":"Qigui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0258964","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}